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ABSTRACT
Objectives: To describe diet, alcohol, physical activity
and tobacco use prospectively, that is, before and
10 months after colonoscopy for patients and their
partners.
Design: Prospective cohort study of health behaviour
change in patients and partners. Comparison groups
are patients receiving a normal result notification
(NRN) versus patients receiving an abnormal result
notification (ARN). Patients and partners (controls) are
also compared.
Setting: 5 Scottish hospitals.
Participants: Of 5798 colonoscopy registrations,
2577 (44%) patients met the eligibility criteria of
whom 565 (22%) were recruited; 460 partners were
also recruited.
Measures: International Physical Activity
Questionnaire, Scottish Collaborative Group Food
Frequency Questionnaire (includes alcohol), smoking
status, sociodemographic characteristics, body mass
index, medical conditions, colonoscopy result,
Multidimensional Health Locus of Control Scale,
behaviour-specific self-efficacy scales.
Results: 57% of patients were men, with a mean age
of 60.8 years (SE 0.5) and 43% were from more
affluent areas. 72% (n=387) of patients received an
ARN and 28% (n=149) received an NRN. Response
rate of the second questionnaire was 68.9%. Overall,
27% of patients consumed <5 measures of fruit and
vegetables/day, 20% exceeded alcohol limits, 50% had
low levels of physical activity and 21% were obese. At
10-month follow-up, a 5% reduction in excessive
alcohol consumption and an 8% increase in low levels
of physical activity were observed among patients; no
significant changes occurred in partners. Baseline high
alcohol consumption and low physical activity were the
strongest predictors of these behaviours at follow-up.
Low alcohol self-efficacy and increasing age were
associated with poorer health-related behaviours at
follow-up for alcohol consumption and physical
activity, respectively.
Conclusions: Colonoscopy is associated with
marginal beneficial changes in some behaviours but
not others. Further work is needed to explore how
services can optimise increases in beneficial
behaviours and mitigate increases in harmful ones.
Registrations: REC REF 10/S0709/24, UKCRN 9911.
INTRODUCTION
Illnesses and interactions with health services
may motivate patients to change their health
behaviours for the better. Such ‘teachable
moments’ have been described for changes
in smoking behaviour following life transi-
tions, such as pregnancy, and health events,
such as screening for lung cancer.1–10 A
recent review of the literature concludes that
while the term ‘teachable moment’ is used
imprecisely—to describe either an opportun-
ity for behavioural change or an event asso-
ciated with actual change—there is evidence
that beneficial behavioural changes can be
actively created through appropriate clin-
ician–patient interactions.11 To our knowl-
edge, evidence from the UK that patients
who undergo screening for cancer are likely
Strengths and limitations of this study
▪ This is the first prospective cohort study on
health behaviours in colonoscopy patients in the
UK.
▪ We obtained a large sample size and high
follow-up rate and were able to use patients’
partners as controls.
▪ Selection biases may have led to our sample
comprising healthier patients than in the general
colonoscopy population.
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to make improvements in health behaviour is limited to
a single pilot study of a health promotion intervention
delivered during colorectal cancer screening.12 The evi-
dence from UK observational research that there are
spontaneous health behaviour changes after a cancer
diagnosis is limited to analyses of population surveys that
depend on self-reported cancer diagnosis and found
little evidence that a cancer diagnosis motivates health-
protective changes.13 Relatives of patients with cancer
may also change their behaviour in response to a famil-
ial diagnosis, but the evidence is limited to one study on
breast cancer.14
Colonoscopy is mainly performed for the diagnosis
of colon and rectal cancer and the current UK rates of
80 procedures/10 000 population are likely to increase
in the future as screening by flexible sigmoidoscopy is
introduced.15 The number of colonoscopies performed
through the Scottish bowel screening programme
almost doubled from 5358 in 2009 to 9296 in 201116; in
England, the number of colonoscopies performed
increased by 38% between 2006–2007 and 2009–2010.17
We hypothesised that colonoscopy represents both con-
cepts of a teachable moment for beneficial health
behaviour change—it may be a time of concern about
a cancer diagnosis and thus be associated with spontan-
eous change1 18 and it may also present an opportunity
for clinicians to promote improvements in behaviours.
An abnormal colonoscopy result may be more likely to
trigger beneficial changes in behaviour, so we com-
pared behaviours between participants with normal
and abnormal test results. Our aim was to describe
health-related behaviours before and after a colonos-
copy among patients and their partners. Our objective
was to carry out a prospective observational study on
patients with colonoscopy and their partners using self-
reported questionnaire survey data immediately before
and 10 months after colonoscopy. As self-efficacy and
locus of control are central to several health behaviour
theories, including the Health Belief Model,19 Social
Cognitive Theory20 and Protection Motivation
Theory,21 we assessed their roles using validated ques-
tionnaires and also recorded physical activity (PA),
tobacco smoking, diet and alcohol consumption. We
hypothesised that study participants with high scores of
self-efficacy and with ‘internal’ locus of control would
change health behaviours for the better following col-
onoscopy. Although there is no cut-off score to define
persons as being high or low self-efficacious Ralph
Schwarzer,22 an expert in self-efficacy measurement,
recommends conducting a median split, which is to
dichotomise the study sample. ‘Health-internals’
believe that the locus of control for health is internal
and that one stays or becomes healthy or sick as a
result of his or her behaviour, whereas ‘health-
externals’ believe that factors which determine their
health are such things as ‘powerful others’ and
‘chance’ over which they have a little control.
METHODS
Study design
We conducted a prospective cohort study of health
behaviour change in patients and their partners before
and 10 months after colonoscopy. Comparison groups
are patients receiving a normal result notification
(NRN) versus patients receiving an abnormal result noti-
fication (ARN), such as colorectal cancer, polyps or
diverticulitis. Health behaviour change of patients and
partners (controls) are also compared.
Setting
Colonoscopy clinics in five hospitals within three Health
Board areas in Scotland, UK. Recruitment occurred
between September 2010 and August 2011.
Participants
Patients were invited by an advertisement for the study
enclosed along with their colonoscopy appointment
letter from the hospital. On attendance for colonoscopy,
clinic staff obtained verbal consent from patients (and, if
present, their partners) to allow the research assistant
(RA) to approach them. If a patient did not wish to be
approached by the RA, consent was sought to retain
non-identifiable data (age, sex and sector level of the
postcode) to assess selection bias. The RA asked the con-
senting participants to complete the baseline (T1) ques-
tionnaire and written consent form at home and return
both in a prepaid addressed envelope. Patients whose
partners were not present were asked to provide the
name and contact details of their partner who was subse-
quently contacted by the RA by telephone about the
study.
Eligibility criteria
Patient inclusion criteria were: (1) referred for colonos-
copy, (2) no past history of cancer, (3) ≥18 years old
and (4) has a partner. Partner inclusion criteria: (1)
≥18 years old and (2) no past history of cancer.
Primary outcome
The primary outcome measure was the extent of change
in individual health behaviours before colonoscopy and
10 months later. Consequently, we selected measures
that ranked individuals along a distribution of amount
of PA, dietary and alcohol intake and tobacco use.
Variables, measures and data sources
Information was self-reported by participants or
obtained from medical records.
Heath-related behaviour variables
The International Physical Activity Questionnaire23 24
was used to categorise participants into low, moderate or
high levels of PA using metabolic equivalent of task
(MET) scores. The Scottish Collaborative Group Food
Frequency Questionnaire (SCG FFQ)25 26 was used to
measure intakes of foods and alcohol. Current smokers
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were defined as those who had smoked at least 100 cigar-
ettes in their entire life and currently smoke.
An aggregate risk behaviour score was calculated based
on generally accepted requirements for risk factor reduc-
tion for most of the main chronic diseases and specific-
ally for prevention of colorectal cancer because
colonoscopy is a main investigation for colorectal cancer
symptoms.27 28 Specifically, we defined high-risk behav-
iour using the Scottish government recommendations29 30
as follows: <5 measures/day of fruit and vegetables; <3
portions/day of bread; >4 (men) and >3 (women) units/
day of alcohol; current smoker and low PA (equivalent to
less than 30 min of moderate intensity activity on at least
5 days of the week). For the purpose of this study, a
‘measure’ as defined in the SCG FFQ was assumed to be
equal to a ‘portion’ of fruit or vegetables.
Demographic variables
Participants self-reported their age, sex, level of educa-
tion, household income, employment status and post-
code (to calculate Scottish Index Multiple Deprivation,
SIMD31).
Clinical variables
Body mass index (BMI) was calculated by dividing
weight (kg) by height squared (m2) using self-reported
values. Participants were categorised as obese if BMI
≥30 kg/m2. Participants self-reported their medical con-
ditions currently being treated by a doctor. Results of
the colonoscopy were obtained from patients’ medical
records. Patients were categorised as receiving an NRN
or ARN such as colorectal cancer, polyps or
diverticulitis.
Psychological variables
Participants’ perceived control over their health-related
behaviours was measured using the Multidimensional
Health Locus of Control (MHLC) Scale.32 33 The instru-
ment measures three dimensions of control: internal,
powerful others and chance. Participants’ self-efficacy
was measured using four separate self-efficacy scales
(smoking, diet, alcohol and PA) recommended by
Schwarzer and colleagues.22 There is no cut-off score to
define persons as being high or low self-efficacious, so
we split the sample at the median, as recommended by
Schwarzer.22
Data collection
The baseline (T1) questionnaire was administered to
patients who attended a colonoscopy clinic between
September 2010 and August 2011. A prepaid envelope
was provided for participants to return the questionnaire
after completing it at home. Participants were requested
to report health behaviours before colonoscopy. There
was no cut-off date for returning the baseline question-
naire. The follow-up questionnaire (T2) was posted
10 months after the clinic date for colonoscopy, between
July 2011 and June 2012.
Bias
We attempted to minimise information biases by using,
where possible, validated questionnaires and to minimise
selection biases by inviting all patients with colonoscopy
to participate.
Statistical analysis
Statistical analysis was carried out using Stata/SE V.11.2
software. Means±SEs or medians (IQR) were presented
as appropriate following visual assessment of histograms
of continuous variables. Differences in characteristics
and behaviours between groups were assessed using
Pearson’s χ2 test for categorical measures and either
Student t tests or Mann-Whitney tests for continuous
variables as appropriate. Differences in continuous vari-
ables between T1 and T2 were assessed using a paired t
test or the Wilcoxon signed-rank test. Differences in cat-
egorical variables between T1 and T2 were assessed in
SPSS V.20 using the McNemar-Bowker test for variables
with three or more categories, and the McNemar test
for binary variables. To predict health-related behaviour
at T2, logistic regression models were undertaken.
Statistical power
Our sample size was based on answering the research
question “Do health behaviours change after a major
health threat?” We used the variable PA to calculate the
statistical power because it has an association with colo-
rectal cancer survival, and detecting colorectal cancer is
one of the main reasons for colonoscopy referral. This
paper reports a comparison of changes in health beha-
viours of patients receiving NRN and ARN following col-
onoscopy. However, the study had initially aimed to
detect an increase in PA of 25 or greater MET hours in
patients diagnosed with cancer at colonoscopy com-
pared with patients with no cancer, and samples of 46
patients with cancer and 46 patients with no cancer
would have been required. The effect size was derived
from Satia et al,34 and sample size calculations assumed
conventional values of α=0.05 and β=0.20 (giving a
power, or 1−β, of 80%). Thus, our study numbers
exceeded those required by the initial sample size
calculation.
RESULTS
Of 5798 colonoscopy registrations, 2577 patients (44%)
met the eligibility criteria for the study of whom 565
(22%) eligible patients and 460 partners were recruited
(figure 1). Recruited patients compared with non-
recruited patients were significantly older (60.3±0.5 vs
57.2±0.4), more affluent (Carstairs decile 1 and 2, 43%
vs 29%) and had a higher proportion of men (57%
men vs 50% men). Seventy-two per cent (n=387) of
patients received an ARN and 28% (n=149) received an
NRN. Overall, 68.9% (n=706) of participants returned a
second follow-up questionnaire at T2. The median times
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for patients and partners to return the baseline ques-
tionnaire was 12 days.
At baseline (T1), a higher proportion of patients with
ARN were men, older, retired and with a household
income under £20 000 compared with patients with NRN
(table 1). Overall, 27% consumed less than five measures
a day of fruit/vegetable, 20% exceeded the recommended
alcohol limits, 50% had low levels of PA and 21% were
obese. A higher proportion of patients with ARN were not
meeting these recommendations but the difference was
only significant for PA. Only 11% of patients reported
current smoking. When combined, overall 52% of partici-
pants had two or more risk behaviours, which comprised
55% of ARN and 42% of NRN patients.
There were no significant differences between patients
with abnormal and normal results with respect to self-
efficacy for smoking cessation, PA, diet and alcohol
(table 2). Partners of patients with normal results were
more likely to have low self-efficacy for smoking
cessation.
Overall, there was a 5% reduction in respondents who
exceeded alcohol consumption guidance and an 8%
increase in the proportion with low PA (table 3). The
proportionate increase in low PA was similar in patients
with abnormal and normal colonoscopy results but statis-
tically significant only among those with abnormal find-
ings (which might be explained by the larger sample
size in the abnormal category). When risk behaviours
were aggregated, there was no overall change in beha-
viours in any patient group. We found no significant
change in health behaviours of partners, irrespective of
the colonoscopy result of the patient (data not shown).
We used multiple logistic regression analyses to
explore the predictors of the two behaviours that
changed significantly over time: low PA and high alcohol
intake (table 4). Low PA at baseline was the strongest
predictor of low PA at T2 among patients, and increas-
ing age was also associated with lower PA. Sex, socio-
economic circumstances, comorbidities, colonoscopy
findings and self-efficacy did not predict changes in PA
over time.
Excessive alcohol consumption at T2 was most strongly
determined by excessive consumption at baseline (table
5). Lower self-efficacy at T1 was associated with higher
alcohol consumption at T2. Age, sex, socioeconomic cir-
cumstances, comorbidities and colonoscopy findings were
not associated with higher alcohol intake at follow-up.
DISCUSSION
Colonoscopy was associated with marginal spontaneous
changes (ie, without a behavioural intervention) in
some health-related behaviours. We found that there was
a 5% reduction in excessive alcohol consumption (a
beneficial change) but an 8% increase in low levels of
PA (a change for the worse) 10 months after colonos-
copy. There were no significant changes in health beha-
viours among patients’ partners, suggesting that
behavioural changes in patients with colonoscopy were
not necessarily part of wider trends that might influence
the health behaviours. No behavioural advice was given
to patients as part of their investigations, and thus colon-
oscopy might be regarded as a teachable moment in
which spontaneous changes are triggered. However,
Figure 1 Recruitment of
participants.
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colonoscopy also represents an interaction with health
services that might be optimised to encourage improve-
ments in health-related behaviours. At baseline, we
found that patients receiving ARN and their partners
scored significantly higher than patients receiving NRN
and their partners on the MHLC Powerful Others scale,
indicating that patients with ARN and their partners
believed more strongly that health professionals were
responsible for their health and health outcomes. Thus,
patients receiving ARN, in particular, may be receptive
to health promotion advice from health professionals.
Our conclusion that colonoscopy may be regarded as a
teachable moment is similar to a recent systematic review
of 11 articles about the impact of cancer screening (9 of
Table 1 Patient and partner baseline characteristics
Patients (n=536) Partners of patients (n=438)
All
(n=536)
ARN
(n=387)
NRN
(n=149) p Value*
ARN
(n=318)
NRN
(n=120) p Value†
Sex
Male 308 (57) 236 (61) 72 (48) 0.008 121 (38) 56 (47) 0.101
Female 228 (43) 151 (39) 77 (52) 197 (62) 64 (53)
Age (years): mean±SE 60.8±0.5 62.1±0.6 57.6±1.1 <0.001 62.0±0.6 56.8±1.2 <0.001
SIMD quintile
1 (most deprived) 41 (8) 31 (8) 10 (7) 0.979 26 (9) 9 (8) 0.425
2 76 (14) 56 (15) 20 (14) 40 (13) 9 (8)
3 91 (17) 65 (17) 26 (18) 48 (16) 25 (22)
4 131 (25) 93 (25) 38 (26) 78 (26) 28 (24)
5 (least deprived) 186 (35) 134 (35) 52 (36) 113 (37) 44 (38)
Highest level of education
School completed 282 (53) 208 (54) 74 (50) 0.578 171 (54) 51 (43) 0.092
College/university 197 (37) 137 (35) 60 (40) 120 (38) 55 (46)
Postgraduation degree
completed
57 (11) 42 (11) 15 (10) 26 (8) 14 (12)
Employment status
Self-employed/paid
employment
231 (43) 153 (40) 78 (52) 0.010 128 (41) 71 (59) 0.001
Not employed 14 (3) 11 (3) 3 (2) 3 (1) 5 (4)
Retired from paid work 252 (47) 196 (51) 56 (38) 154 (49) 38 (32)
Looking after family-home 22 (4) 12 (3) 10 (7) 24 (8) 4 (3)
Long-term sick or disabled 15 (3) 13 (3) 2 (1) 7 (2) 2 (2)
Household income
Under £20 000 138 (30) 108 (32) 30 (25) 0.040 85 (31) 29 (28) 0.002
£20 000–29 999 99 (21) 79 (23) 20 (17) 71 (26) 12 (12)
£30 000–39 000 60 (13) 46 (13) 14 (12) 43 (16) 13 (13)
£40 000–49 000 61 (13) 42 (12) 19 (16) 25 (9) 13 (13)
£50 000 and above 104 (23) 66 (19) 38 (31) 53 (19) 37 (36)
Physical activity
(MET-min/week)
4152
(1997, 7668)
4381
(2157, 7338)
0.801 4250
(1980, 8406)
4134
(1964, 8178)
0.917
Risk behaviour
<5 measures/day of fruit
and vegetables
93 (27) 70 (28) 23 (25) 0.493 62 (29) 20 (27) 0.764
<3 measures/day of bread
and consume white bread
only
75 (15) 54 (15) 21 (15) 0.989 49 (16) 12 (10) 0.126
>4 (men) and >3 (women)
units/day of alcohol
88 (20) 67 (22) 21 (17) 0.267 36 (14) 26 (28) 0.002
Current smoker 54 (11) 36 (10) 18 (13) 0.320 36 (12) 19 (17) 0.169
Low physical activity level 203 (50) 159 (54) 44 (40) 0.009 135 (53) 40 (41) 0.050
Obese (BMI ≥30 kg/m2) 92 (21) 70 (23) 22 (18) 0.355 44 (19) 25 (26) 0.205
Risk behaviour score group
1 or less 154 (48) 102 (45) 52 (58) 0.026 88 (45) 31 (44) 0.930
2 or more 164 (52) 127 (55) 37 (42) 108 (55) 39 (56)
Bold font represents p values of ≤0.05. Italic font are p>0.05.
*p Values for difference between patients.
†p Values for difference between partners.
ARN, abnormal result notification; BMI, body mass index; MET, metabolic equivalent of task; NRN, normal result notification and SIMD,
Scottish Index Multiple Deprivation.
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Table 2 Self-efficacy and scores at baseline (patients on ARN and NRN and their partners): median (IQR)
Patients Partners of patients
ARN (n=387) NRN (n=149) p Value* ARN (n=318) NRN (n=120) p Value†
Smoking cessation self-efficacy‡
Score (range 5–20) 12 (9, 16) 13 (9, 18) 0.355 11 (9, 14) 10 (7, 12) 0.055
Low (5–12): n (%) 20 (51) 8 (42) 0.512 20 (54) 14 (82) 0.045
High (13–20): n (%) 19 (49) 11 (58) 17 (46) 3 (18)
Physical activity self-efficacy
Score (range 5–20) 14 (11, 15) 14 (12, 18) 0.073 14 (11, 17) 14 (10, 16) 0.948
Low (5–14): n (%) 205 (55) 76 (52) 0.530 163 (53) 65 (56) 0.588
High (15–20): n (%) 167 (45) 70 (48) 144 (47) 51 (44)
Diet self-efficacy
Score (range 5–20) 15 (14, 18) 15 (14, 20) 0.121 15 (14, 19) 15 (12, 20) 0.875
Low (5–15): n (%) 230 (62) 84 (59) 0.566 191 (62) 73 (64) 0.731
High (16–20): n (%) 144 (39) 59 (41) 116 (38) 41 (36)
Alcohol resistance self-efficacy
Score (range 3–12) 9 (7, 12) 10 (7, 12) 0.657 11 (8, 12) 10 (7, 12) 0.530
Low (3–10): n (%) 187 (55) 71 (55) 0.956 133 (48) 55 (51) 0.511
High (11–12): n (%) 151 (45) 58 (45) 146 (52) 52 (49)
MHLC Internal
Score (range 6–36) 25 (22, 28) 26 (21, 29) 0.381 26 (22, 28) 26 (22, 29) 0.696
Low (6–25): n (%) 203 (53) 72 (49) 0.415 152 (48) 59 (50) 0.783
High (26–36): n (%) 183 (47) 76 (51) 164 (52) 60 (50)
MHLC Chance
Score (range 6–36) 17 (13, 21) 17 (13, 21) 0.335 18 (14, 22) 17 (13, 22) 0.788
Low (6–17): n (%) 197 (51) 83 (56) 0.332 154 (49) 61 (51) 0.638
High (18–36): n (%) 189 (49) 66 (44) 162 (51) 58 (49)
MHLC Powerful Others
Score (range 6–36) 18 (14, 23) 17 (12, 21) 0.032 18 (13, 22) 15 (11, 20) 0.018
Low (6–17): n (%) 186 (48) 77 (52) 0.442 154 (49) 75 (63) 0.008
High (18–36): n (%) 199 (52) 71 (48) 162 (51) 44 (37)
Bold font represents p values of ≤0.05. Italic font are p≥0.05.
*p values for difference between patients.
†p values for difference between partners.
‡Current smokers only.
ARN, abnormal result notification; MHLC, Multidimensional Health Locus of Control; NRN, normal result notification.
Table 3 Change in patient risk behaviours between T1 and T2: n (%)
All patients (n=418)* ARN (n=387) NRN (n=149)
T1 T2 p Value† T1 T2 p Value† T1 T2 p Value‡
Risk behaviour
<5 measures/day of fruit and
vegetables
38 (23) 40 (24) 0.845 28 (24) 30 (26) 0.815 9 (20) 7 (15) 0.687
<3 measures/day of bread and
consume white bread only
46 (12) 43 (11) 0.766 34 (13) 30 (11) 0.585 11 (11) 10 (10) 1.000
>4 (men) and >3 (women)
units/day of alcohol
58 (21) 45 (16) 0.047 41 (22) 31 (17) 0.064 14 (17) 13 (16) 1.000
Current smoker 27 (8) 24 (7) 0.250 15 (6) 13 (5) 0.500 10 (10) 9 (9) 1.000
Low physical activity level 131 (50) 150 (58) 0.003 98 (54) 112 (61) 0.019 25 (40) 29 (46) 0.055
Moderate physical activity 37 (14) 41 (16) 24 (13) 28 (15) 9 (14) 11 (17)
High physical activity 92 (35) 69 (27) 61 (33) 43 (24) 29 (46) 23 (37)
Obese (BMI≥30 kg/m2) 56 (19) 64 (22) 0.152 43 (21) 49 (24) 0.238 10 (14) 11 (15) 1.000
Risk behaviour score group (number of risk behaviours)
1 or less 84 (54) 80 (51) 0.572 52 (49) 47 (44) 0.359 29 (67) 30 (70) 1.000
2 or more 73 (47) 77 (49) 55 (51) 60 (56) 14 (33) 13 (30)
Bold font represents p values of ≤0.05. Italic font are p>0.05.
*Includes patients with missing diagnosis.
†p values for difference between T1 and T2 in patients with an abnormal diagnosis
‡p values for difference between T1 and T2 in patients with a normal diagnosis
ARN, abnormal result notification; BMI, body mass index; NRN, normal result notification.
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which investigated the impact of lung screening on
smoking cessation) which concluded that cancer screen-
ing ‘might’ be a teachable moment for health behaviour
change.35 Research about change in health behaviours
after diagnosis of chronic health conditions indicates, at
best, only modest changes.36 Thus, based on the current
evidence, it remains uncertain whether and the extent to
which major health events represent teachable moments.
Health behaviours are likely to be influenced by a
complex mix of factors, so that in addition to any benefi-
cial teachable moment effects, ongoing symptoms that
prompted colonoscopy may also affect behaviour. These
may explain reductions in high levels of PA and concomi-
tant increases in low levels.
We found that baseline health behaviours for low PA
and excessive alcohol consumption were the strongest pre-
dictors of the same behaviours 10 months after colonos-
copy but, additionally, increasing age predicted lower PA
and lower self-efficacy around alcohol-predicted excessive
alcohol consumption at follow-up. Among our patient
sample, 11% smoked, which is much lower than the
Scottish general adult population prevalence of 23%.37
This study found that a low level of PA at the time of
colonoscopy and increasing age were predictive of a low
level of PA 10 months postcolonoscopy. Furthermore,
high alcohol intake at the time of colonoscopy and low
alcohol self-efficacy were predictive of high alcohol
intake postcolonoscopy. Of note, fatalism (MHLC
Table 4 Predictors of low PA at T2 in patients (n=268)
OR 95% CI p Value
Low PA at T1 (vs high) 26.2 (9.57 to 71.7) <0.001
Age (years) 1.07 (1.02 to 1.12) 0.005
Female sex (vs male) 0.73 (0.29 to 1.81) 0.495
SIMD quintile
1 1.00
2 0.98 (0.14 to 6.67) 0.981
3 1.65 (0.23 to 11.8) 0.618
4 4.93 (0.77 to 31.6) 0.093
5 1.70 (0.29 to 10.1) 0.558
Any medical conditions (vs none) 1.13 (0.44 to 2.93) 0.801
ARN (vs NRN) 1.17 (0.44 to 3.13) 0.749
Raw MHLC Internal score 0.96 (0.88 to 1.05) 0.421
Raw MHLC Chance score 0.99 (0.91 to 1.07) 0.775
Raw MHLC Powerful Others score 1.06 (0.98 to 1.15) 0.126
Raw PA self-efficacy score 0.99 (0.96 to 1.02) 0.517
Raw time spent sitting per day (including motor vehicle) 1.00 (0.99 to 1.00) 0.922
Constant 0.004 (0.00 to 0.26) 0.009
Bold font represents p values of ≤0.05. Italic font are p>0.05.
ARN, abnormal result notification; MHLC, Multidimensional Health Locus of Control; NRN, normal result notification; PA, physical activity;
SIMD, Scottish Index Multiple Deprivation.
Table 5 Predictors of high alcohol intake at T2 in patients (n=232)
OR 95% CI p Value
>4 (men) and >3 (women) units/day alcohol at T1 12.4 (4.83 to 31.5) <0.001
Age (years) 0.99 (0.95 to 1.03) 0.601
Female sex (vs male) 1.02 (0.39 to 2.63) 0.975
SIMD quintile
1 1.00
2 4.87 (0.48 to 49.5) 0.181
3 3.23 (0.33 to 31.5) 0.313
4 1.23 (0.15 to 10.1) 0.847
5 1.96 (0.24 to 15.8) 0.525
Any medical conditions (vs none) 0.66 (0.23 to 1.89) 0.441
Abnormal diagnosis (vs normal) 0.83 (0.29 to 2.34) 0.725
Raw MHLC Internal score 1.00 (0.92 to 1.08) 0.988
Raw MHLC Chance score 0.97 (0.88 to 1.07) 0.556
Raw MHLC Powerful Others score 1.00 (0.93 to 1.08) 0.905
Raw alcohol self-efficacy score 0.70 (0.58 to 0.84) <0.001
Constant 3.74 (0.04 to 360.3) 0.572
Bold font represents p values of ≤0.05. Italic font are p>0.05.
MHLC, Multidimensional Health Locus of Control; SIMD, Scottish Index Multiple Deprivation.
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Chance score) was not predictive of any differential
health behaviour change. ARN was not predictive of
health behaviour change following this health event,
which is in contrast to studies of smokers undergoing
screening for lung disease.38 39 A cross-sectional study of
over 10 000 smokers at 2–3 years postscreening for
chronic obstructive pulmonary disease found that those
with a first-time positive result were significantly more
likely to stop smoking than those with a negative result.38
A cross-sectional study of 134 active smokers who under-
went spiral CT screening found that 62% of those with a
positive result either stopped or decreased smoking,
whereas only 46% with a negative result did so.39 Thus,
the effect of test results following screening for disease
on health-related behaviour appears to vary according to
type of screen (eg, colonoscopy vs spiral CT), reason for
screening (eg, colon disease vs lung disease) and
health-related behaviour (eg, alcohol vs smoking).
Our study has strengths and limitations. This is the
first prospective observational study to report
health-related behaviours of patients and their partners
before and 10 months after colonoscopy. We used vali-
dated questionnaire survey tools, obtained a relatively
large sample for a prospective cohort study and
achieved high follow-up rates of 69%. There are,
however, several study limitations. First, the sample may
not be representative of all patients undergoing colon-
oscopy. The response rate of eligible patients was 22%,
and there was some selection bias towards a more afflu-
ent, older and male population. Socioeconomic afflu-
ence may explain why our sample had a lower smoking
prevalence than the general population. Patients who
participate in the newly introduced national colorectal
cancer screening programme also may be more likely
to be motivated to change their behaviour. Second,
while participants were requested to self-report health
behaviours before the colonoscopy and as soon as pos-
sible thereafter, the baseline questionnaire was com-
pleted after the colonoscopy when participants may
already have been influenced and starting to make
some changes and there was no cut-off date for return-
ing the baseline questionnaire. Thus, the observed
changes for the better or worse in health behaviours
may be an underestimation of the extent of change.
Third, although valid and reliable survey instruments
were used, self-reported data are susceptible to expect-
ation biases and other misclassification effects.40
However, our principal interest was in behavioural
change rather than absolute prevalences of behaviours,
and thus over-reporting or under-reporting of certain
behaviours would not necessarily invalidate our find-
ings on whether they changed after colonoscopy. The
observed decreases in excessive alcohol consumption
and in PA following colonoscopy may not be caused by
the procedure but by other confounding factors that
we have not identified. We are not aware of any health
promotion activity associated with colonoscopy as it was
delivered within the participating hospitals and our
questionnaires were designed not to imply any favour-
able behaviours. The fact that there were no observed
changes in partners and no differences between
patients receiving ARN and NRN suggests that the
observed behavioural changes in patients were related
to the colonoscopy.
Healthcare settings are recognised as important loci for
promoting health behaviour change41–43 and health
events have been conceptualised as a ‘teachable moment’,
particularly in relation to smoking cessation.1–10
Conceptualising health events as teachable moments may
be appealing to policymakers and clinicians because they
represent an opportunity to introduce low-intensity inter-
ventions to change modifiable risk of health-related beha-
viours to prevent disease, and a recent review has
identified nine lifestyle interventions at the point of
cancer screening to take advantage of this health event as
a ‘teachable moment’, including two studies of a multiple
lifestyle intervention offered to people who had under-
gone colonoscopy and had adenomas removed.44 45
For future research, developing and testing the effect
of low-intensity interventions (eg, self-efficacy enhance-
ment) to further reduce alcohol consumption may be
appropriate because patients appear to spontaneously
reduce alcohol consumption following colonoscopy,
whereas more intense interventions may be required for
health-related behaviours that do not change (eg, diet)
or change for the worse (eg, PA). A qualitative study to
understand why patients spontaneously change some
health behaviours but not others following a major
health event will add to understanding about the utility
of teachable moments for public health.
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